Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2378 posts found.

GSK to acquire Aiolos Bio for $1bn

January 9, 2024 Business Services Aiolos Bio, GSK, Pharmacy, acquisition

GSK and Aiolos Bio have announced that they have entered into an agreement for GSK to acquire Aiolos for an …
News

Calypso Biotech to be acquired by Novartis for $250m

January 8, 2024 Business Services Calypso Biotech, Immunology, Novartis, acquisition

Calypso Biotech has announced that it has entered into an agreement to be acquired by Novartis. The company’s shareholders will …
News

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023 Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …
News

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023 Business Services AbbVie, Cerevel Therapeutics, Neurology, acquisition

AbbVie and Cerevel Therapeutics have announced an agreement in which AbbVie will acquire Cerevel Therapeutics for $45 per share, or …
News

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023 Business Services Kling Bio, Oncology, appointment, chief scientific officer

Kling Bio has announced the appointment of Dr Stefano Gulià as chief scientific officer. Dr Gulià has over 15 years …
Appointment

Roche to acquire Carmot Therapeutics for $2.7bn

December 4, 2023 Business Services Obesity, Roche, acquisition, diabetes

Roche has announced that it has entered into a definitive merger agreement with Carmot Therapeutics, in which it will acquire …
News

Syncona to acquire Freeline Therapeutics for $28.3m

November 24, 2023 Business Services Freeline Therapeutics, Pharmacy, acquisition, syncona

Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …
News

Merck to acquire Caraway Therapeutics for up to $610m

November 22, 2023 Business Services Caraway Therapeutics, MSD, Merck, Pharmacy, acquisition

Merck (known as MSD outside of the US and Canada) and Caraway Therapeutics have announced that they have entered into …
News
carlos-muza-hpjsku2uysu-unsplash_1

AstraZeneca launches health-tech business, Evinova

November 21, 2023 Business Services AstraZeneca, Pharmacy, health-tech

AstraZeneca has announced that it has launched Evinova, its new health-tech business, which it is hoped will become a leading …
News

Astellas Pharma to acquire Propella Therapeutics for $175m

November 20, 2023 Business Services Astellas Pharma, Oncology, Properlla Therapeutics, acquisition

Astellas Pharma and Propella Therapeutics have announced that Astellas and Propella have entered a merger agreement in which Astellas will …
News

Prange Group and Adragos Pharma to acquire Fresenius Kabi’s manufacturing site

November 16, 2023 Business Services Fresenius Kabi, Pharmacy, Prange Group, acquisition

Prange Group and Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for their acquisition of its …
News
milad-fakurian-58z17lnvs4u-unsplash_2

Autifony announces global license and collaboration agreement with Jazz Pharmaceuticals

November 14, 2023 Business Services Autifony, Neurology, collaboration, jazz pharmaceuticals, neurological disorders

Autifony Therapeutics has announced that it has entered an exclusive global licensing agreement with Jazz Pharmaceuticals for up to $770.5m, …
News

Enhanc3D Genomics appoints Hazel Jones as chief operating officer

November 14, 2023 Business Services Enhanc3D Genomics, Hazel Jones, chief operating officer

Enhanc3D Genomics has announced the appointment of Hazel Jones as chief operating officer. This appointment marks part of the company’s …
Appointment

Anthony Johnson appointed NanoSyrinx’s non-executive director

November 14, 2023 Business Services Anthony Johnson, NanoSyrinx, non-executive director

NanoSyrinx has announced the appointment of Anthony Johnson MD to its board as non-executive director. This appointment marks part of …
Appointment

Halozyme and Acumen Pharmaceuticals enter collaboration for Alzheimer’s treatment

November 7, 2023 Business Services Acumen Pharmaceuticals, Alzheimer's disease, Halozyme, Neurology, collaboration

Halozyme Therapeutics has announced a global collaboration and non-exclusive license with Acumen Pharmaceuticals, providing Acumen with access to Halozyme’s Enhanze …
News

Latest content

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024

Vertex shares results from phase 1/2 trial of type 1 diabetes treatment

June 24, 2024

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024